The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider New Enterprise Associates 14, L.p. since year 2005.
The trader's CIK number is 1544328.
At the time of this reporting, New Enterprise Associates 14, L.p. is the 10% Owner of Surface Oncology, Inc. .
(stock ticker symbol SURF).
See this page for all insider trading activities at Surface Oncology, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-23||SURF||Surface Oncology, Inc.||Buy||133,333||15.00||1,999,995|
|2016-07-29||ILIU||Interleukin Genetics Inc||Buy||20,120,724||.10||1,991,951|
|2015-10-06||MIRN||Mirna Therapeutics, Inc.||Buy||857,142||7.00||5,999,994|
|2014-12-23||ILIU||Interleukin Genetics Inc||Buy||19,868,965||.10||1,986,896|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by New Enterprise Associates 14, L.p. (10% Owner of Surface Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.